Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > LGVN Longeveron > Detailed Quotes

LGVN Longeveron

Watchlist
4.040
+0.048+1.20%
Close  02/03 16:00 ET
4.0400.0000.00%
Post Mkt Price 02/03 18:55 ET
High
4.180
Open
4.050
Turnover
146.90K
Low
3.930
Pre Close
3.992
Volume
36.08K
Market Cap
84.91M
P/E(TTM)
Loss
52wk High
16.770
Shares
21.02M
P/E(Static)
Loss
52wk Low
2.800
Float Cap
21.85M
Bid/Ask %
0.00%
Historical High
45.000
Shs Float
5.41M
Volume Ratio
0.54
Historical Low
2.800
Dividend TTM
--
Div Yield TTM
--
P/B
3.45
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.67%
Amplitude
6.26%
Avg Price
4.071
Lot Size
1
Float Cap
21.85M
Bid/Ask %
0.00%
Historical High
45.000
Shs Float
5.41M
Volume Ratio
0.54
Historical Low
2.800
Dividend TTM
--
P/B
3.45
Dividend LFY
--
Turnover Ratio
0.67%
Amplitude
6.26%
Avg Price
4.071
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Longeveron, Inc. is a clinical stage biotechnology company. It engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffers on October 9, 2014 and is headquartered in Miami, FL.
CEO: Mr. Geoff Green
Market: NASDAQ
Listing Date: 02/12/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist